Low-Temperature Thymoquinone–Harmaline Synthesis for Product Selectivity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for synthesizing thymoquinone/harmaline compounds yield low quantities of desirable products with molecular weights of 360 to 380 and produce significant amounts of higher molecular weight species, requiring separation and leading to inefficient production.

Innovation Solution

The synthesis is conducted at low temperatures below 10°C, preferably between −10°C and −100°C, for a duration of 4 hours to 14 days, using high-purity thymoquinone and harmaline in noninterfering solvents like C1-C4 alcohols or dimethyl sulfoxide, to enhance the yield of reaction products with molecular weights of 360 to 380.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If the reaction is carried out at higher temperatures (20-60°C) for a shorter duration, then the reaction time is reduced, but the yield of desirable products with molecular weights of 360-380 is low (less than 20% by weight) and significant quantities of higher molecular weight species are produced

Engineering Contradiction:
Improvereaction timeVSAvoidproduct selectivity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent changes the temperature parameter from conventional ranges (20-60°C) to sub-zero temperatures (-10°C to -100°C), which fundamentally alters the reaction pathway to favor formation of products with molecular weights 360-380 while minimizing higher molecular weight byproducts, achieving at least 35% by weight yield of desirable products

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If the reaction is carried out at low temperatures (-10°C to -100°C) for extended periods, then the yield of desirable products with molecular weights of 360-380 is increased (at least 35% by weight), but the reaction time is extended to 4 hours to 14 days

Engineering Contradiction:
Improveproduct selectivityVSAvoidreaction time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent employs extreme temperature parameter change (to -100°C or lower) that accelerates the selective formation of desired products, achieving at least 35% by weight yield within 4-14 days, representing an optimization between selectivity and time consumption

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If conventional synthesis methods are used, then the process is simpler to operate, but significant quantities of higher molecular weight species above MW 500 are produced that must be separated from desired end products

Engineering Contradiction:
Improveprocess simplicityVSAvoidbyproduct formation
Core Design Contradiction:
Ease of operationVSLoss of substance

Solution Approach 1:

By changing the temperature parameter to sub-zero ranges, the patent modifies the reaction mechanism to inherently favor formation of products with molecular weights 360-380, minimizing formation of higher molecular weight species above MW 500 and reducing the need for complex separation processes

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method significantly increases the production of thymoquinone/harmaline compounds with molecular weights of 360 to 380, achieving yields of at least 35% by weight, with preferred products being 378, while minimizing higher molecular weight byproducts.

Implementation Method 1

carrying out the reaction between thymoquinone and harmaline at a temperature of less than about 10° C. Desirably, the reaction temperature is less than about 0° C., and more preferably ranges from about −10° C. to about −100° C.

Methodology Applied
Scientific EffectLow-temperature synthesis: Cooling

Data Source

PatentUS12419872B2Low-temperature synthesis of thymoquinone and harmaline compounds
Publication Date: 2025.09.23 ANKH LIFE SCI LTD
  • US12419872B2 patent drawing
  • US12419872B2 patent drawing
  • US12419872B2 patent drawing

AI summary

Low-temperature syntheses of thymoquinone/harmaline compounds which are useful for the treatment of human diabetes and cancers, and the derivatives, solvates, prodrugs, isomers, and tautomers of such compounds.